Endoscopic Injection Sclerotherapy Versus N-butyl-2-cyanoacrylate Injection
Last updated on July 2021Recruitment
- Recruitment Status
- Active, not recruiting
- Estimated Enrollment
- 100
Summary
- Conditions
- Bleeding Esophageal Varices
- Type
- Interventional
- Phase
- Phase 3
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Younger than 125 years
- Gender
- Both males and females
Description
Endoscopic Injection Sclerotherapy versus N-butyl-2-cyanoacrylate Injection in the Management of Actively Bleeding Esophageal Varices
Endoscopic Injection Sclerotherapy versus N-butyl-2-cyanoacrylate Injection in the Management of Actively Bleeding Esophageal Varices
Tracking Information
- NCT #
- NCT03388125
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Mohamed Alsebaey, MD Gastroenterology Study Director: Mohamed Abdelraouf, MD Gastroenterology Study Director: Sherief Abd-Elsalam, MD Hepatology and Gastroenterology
Get Well Soon